The 8406.HK stock tumbled 24.05% after hours on 17 Mar 2026, slipping to HK$0.06 on the HKSE as volume spiked to 3,920,000.00 shares. Traders reacted to weak fundamentals and a low float trading against an already depressed share price. This article reviews the immediate price action, key financial metrics, technical signals, and what analysts and active traders should watch next for China Oral Industry Group Holdings Limited on the Hong Kong market.
After hours price action and volume
China Oral Industry Group (8406.HK) closed the regular session at HK$0.06 and recorded an after-hours drop of 24.05% from the previous close of HK$0.079. The company traded 3,920,000.00 shares today versus an average daily volume of 1,128,245.00, giving a relative volume of 2.06 and confirming heavier selling pressure. Market participants should note the intraday range with a day high HK$0.069 and day low HK$0.06 which highlights thin bid depth at current levels.
8406.HK stock: Financial snapshot and valuation
At HK$0.06, China Oral’s market capitalisation is approximately HK$91,656,000.00 with 1,368,000,000.00 shares outstanding. Key valuation metrics include EPS -0.01, PE -6.70, Price/Book 0.57, and Price/Sales 0.37. The company reports book value per share HK$0.10 and cash per share HK$0.06, reflecting modest tangible support versus the current price. These figures point to a low market valuation but negative profitability, with a trailing net margin of -6.15% and ROE of -10.74%.
Technical signals and short-term momentum
Technical indicators are mixed: RSI 47.35 is neutral while ADX 30.15 signals a strong trend, currently downward given the price collapse. The 50-day average sits at HK$0.06 and the 200-day average at HK$0.09, showing the stock below its longer-term mean. On-chain volume metrics show an OBV -17,480,000.00, reinforcing that outflows dominated the move. Traders may watch the HK$0.05–HK$0.06 zone as immediate support and HK$0.08–HK$0.09 as initial resistance on any rebounds.
Meyka AI rates 8406.HK with a score out of 100
Meyka AI rates 8406.HK with a score out of 100: 56.29 (Grade C+, suggestion: HOLD). This proprietary grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company score reflects low valuation metrics (PB 0.57) but negative profitability and cash flow, creating a mixed risk-reward profile for Hong Kong investors.
Meyka AI forecast, price targets and outlook
Meyka AI’s forecast model projects a 12-month price of HK$0.08543 and a monthly near-term level of HK$0.05. Compared with the current HK$0.06, that implies a potential upside of 42.38% to the 12-month model target and a downside of -16.67% to the monthly level. Forecasts are model-based projections and not guarantees. Analysts looking at 8406.HK stock should weigh that implied upside against weak margins and limited liquidity.
Risks, catalysts and sector context
Primary risks include continued negative profitability, thin liquidity, and sensitivity to export demand in the leisure/inflatable-products market. Key ratios: current ratio 3.57, debt/equity 0.02, and net debt/EBITDA ~7.52 signal low leverage but strained earnings. Sector peers in Consumer Cyclical generally show better ROE and margins; the sector has a one-year performance near 6–20% for larger peers, highlighting relative underperformance at China Oral.
Potential catalysts include quarterly earnings improvements, stronger export orders, or corporate actions to narrow the gap between book value and market value. Short-term traders should monitor volume spikes and any company announcements on orders or restructuring.
Final Thoughts
Today’s after-hours sell-off left 8406.HK stock trading at HK$0.06, down 24.05% on 17 Mar 2026, with volume rising to 3,920,000.00. The move reflects a blend of weak profitability (EPS -0.01) and low liquidity, despite supportive balance-sheet metrics such as cash per share HK$0.06 and a current ratio 3.57. Meyka AI rates the stock 56.29/100 (C+, HOLD) and models a 12-month target of HK$0.08543, implying +42.38% upside from today’s level. The short-term monthly model sits at HK$0.05, implying -16.67% downside. Investors should treat these forecasts as model-based projections and not guarantees. For Hong Kong traders, the trade-off is clear: attractive upside relative to current price but elevated execution risk because of thin trading, negative margins, and sector headwinds. Monitor upcoming announcements and volume confirmation before adding exposure. Meyka AI provides this analysis as an AI-powered market analysis platform, not investment advice.
FAQs
What caused the 24.05% drop in 8406.HK stock today?
The decline followed heavy selling on thin bids, negative profitability metrics, and no offsetting positive news. Volume rose to 3,920,000.00 shares, indicating stronger outflows versus the average 1,128,245.00.
What is Meyka AI’s 12-month forecast for 8406.HK stock?
Meyka AI’s forecast model projects HK$0.08543 in 12 months, implying +42.38% upside from the current HK$0.06. Forecasts are model-based projections and not guarantees.
Is China Oral (8406.HK) undervalued based on fundamentals?
Valuation ratios like PB 0.57 and P/S 0.37 point to low market pricing, but negative margins and EPS -0.01 raise concerns. The balance sheet shows low leverage and cash per share HK$0.06.
What short-term supports and resistances should traders watch?
Watch the HK$0.05–HK$0.06 support zone and resistance near HK$0.08–HK$0.09. A volume-backed move through these levels would alter the short-term bias.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)